Press Releases
Fujifilm partners with Dr. Reddys and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
FUJIFILM Corporation partners with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company headquartered in India and Global Response Aid, a global provider of medical supplies...
Packaging & Labelling
SCHOTT delivers pharma vials to package 2 billion doses of COVID-19 vaccines
SCHOTT supports the world’s fight against COVID-19 with vials capable of holding up to 2 billion vaccination doses. The glassmaker and pharma packaging specialist has...
Packaging & Labelling
DHL and Air France KLM Martinair Cargo Make Transports of medicinal products more transparent
DHL Global Forwarding, the air and ocean freight specialist of Deutsche Post DHL Group, and Air France KLM Martinair (AFKLMP) Cargo improve transparency in the...
Clinical Trials
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology...
Press Releases
Bormioli Pharma invests in Type I glass vial production for injectable medicines and vaccines
The company invested more than 50 million euros in the last months for improving its production platform, including a brand-new glass furnace in Bergantino, the...
Drug Research
Stevanato Group signs an agreement with the CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development
Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, and CEPI (the Coalition for Epidemic Preparedness Innovations)...
Clinical Trials
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an effective...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.